Skip to main content

Smarter Data is in Our DNA

At NashBio, we make complex healthcare data easy to use. From idea to execution, we leverage real-world clinical, genomic and imaging data to advance the discovery and development of new therapeutics and diagnostics.

Smarter Data is in Our DNA

At NashBio, we make complex healthcare data easy to use. From idea to execution, we leverage real-world clinical, genomic and imaging data to advance the discovery and development of new therapeutics and diagnostics.

Our Approach

Modern healthcare systems produce endless amounts of data, but finding the right data to enhance your organization’s research and development activity can be a big challenge.

 

Our approach focuses on your use case:
tailoring a multimodal dataset to your unique specifications to achieve an optimal return on your clinical, operational and financial investment.

Our Approach

Modern healthcare systems produce endless amounts of data, but finding the right data to enhance your organization’s research and development activity can be a big challenge.

Our approach focuses on your use case: tailoring a multimodal dataset to your unique specifications to achieve an optimal return on your clinical, operational and financial investment.

The NashBio Difference

Curated Real-World Data

Advance novel discoveries and products with real-world data enabled for research and discovery.

Multimodal & Multi-Omic Data

Seamlessly integrate diverse data types to unlock the full spectrum of biological information.

Enriched Phenotypes

Identify cohorts with a breadth of disease-specific features and years of longitudinal clinically relevant data.

Demographically Diverse

Select patients from a diverse population relative to age, disease and other demographics.

Industry Experts

Collaborate with our scientific and clinical experts to find the right data for your use case.

Strategic Partners

Accelerate speed to market with our flexible, customer-centric approach and proven commercial track record.

Our clients and partners include many of the world’s leading health care organisations.

Our Products

Our offerings leverage the richest and largest de-identified EMR and linked bio-specimen repository in the world, BioVU®.

loader-icon

Clinical Data

Smarter data that enables research and discovery

When patients visit Vanderbilt University Medical Center (VUMC), their clinical encounters are documented in VUMC’s electronic health record (EHR). NashBio’s Clinical Data is a synthetic derivative of this EHR, created to enable research and discovery, and is the backbone of our offerings.

 

Learn more

Genetic Data

Smarter data that enables precise medical care

Precision medicine, an approach to patient care that is tailored to the individual, is an attainable goal. A key component of precision medicine is a patient’s genes and how their genes influence their risk of disease & progression and their response to treatment. NashBio’s data covers both the phenotypic and the genotypic patient data, enabling the interrogation of these interactions.

 

Learn more

Biosamples

Smarter data that enables better insights into disease

Biological samples offer insight into the molecular processes at play in our cells and deepen our understanding of human disease. BioVU® is a collection of biosamples that are linked to patients’ electronic health records and scrubbed of all personal identifiers. Assays may be performed on these biosamples to generate new omic data linked to each patient’s phenome.

 

Learn more

Medical Imaging

Smarter data that enables better diagnostic tools

Images are a powerful tool for diagnostic and interventional purposes. By nature, medical imaging is non to minimally invasive, and consequently is a preferred procedure when monitoring and when repeat acquisition are required. When these images are linked to a patient’s EHR, they enable the development of deep, longitudinal, multi-modal phenotypes.

 

Learn more

Waveforms

Waveform data are a key component of many clinical decision workflows

Care teams rely on real-time monitoring from electrocardiograms (ECGs), mechanical ventilators, electroencephalograms (EEGs) and other high frequency data streams to quickly detect changes in a patient’s health and guide decision making for safe and effective treatment plans.

 

Learn more

Advanced Analyses

Smarter data that enables deeper analysis and discovery

Large-scale association analyses are commonly performed to link phenotypic and genomic datasets. Study findings may elucidate new targets for drug discovery, expand existing drug labels or new populations that would benefit from a therapeutic. NashBio’s 90,000-subject MEGAEX + linked de-identified electronic health records dataset serves as the substrate for our association studies.

 

Learn more

loader-icon

Clinical Data

Smarter data that enables research and discovery

When patients visit Vanderbilt University Medical Center (VUMC), their clinical encounters are documented in VUMC’s electronic health record (EHR). NashBio’s Clinical Data is a synthetic derivative of this EHR, created to enable research and discovery, and is the backbone of our offerings.

 

Learn more

Genetic Data

Smarter data that enables precise medical care

Precision medicine, an approach to patient care that is tailored to the individual, is an attainable goal. A key component of precision medicine is a patient’s genes and how their genes influence their risk of disease & progression and their response to treatment. NashBio’s data covers both the phenotypic and the genotypic patient data, enabling the interrogation of these interactions.

 

Learn more

Biosamples

Smarter data that enables better insights into disease

Biological samples offer insight into the molecular processes at play in our cells and deepen our understanding of human disease. BioVU® is a collection of biosamples that are linked to patients’ electronic health records and scrubbed of all personal identifiers. Assays may be performed on these biosamples to generate new omic data linked to each patient’s phenome.

 

Learn more

Medical Imaging

Smarter data that enables better diagnostic tools

Images are a powerful tool for diagnostic and interventional purposes. By nature, medical imaging is non to minimally invasive, and consequently is a preferred procedure when monitoring and when repeat acquisition are required. When these images are linked to a patient’s EHR, they enable the development of deep, longitudinal, multi-modal phenotypes.

 

Learn more

Waveforms

Waveform data are a key component of many clinical decision workflows

Care teams rely on real-time monitoring from electrocardiograms (ECGs), mechanical ventilators, electroencephalograms (EEGs) and other high frequency data streams to quickly detect changes in a patient’s health and guide decision making for safe and effective treatment plans.

 

Learn more

Advanced Analyses

Smarter data that enables deeper analysis and discovery

Large-scale association analyses are commonly performed to link phenotypic and genomic datasets. Study findings may elucidate new targets for drug discovery, expand existing drug labels or new populations that would benefit from a therapeutic. NashBio’s 90,000-subject MEGAEX + linked de-identified electronic health records dataset serves as the substrate for our association studies.

 

Learn more

Creating Custom Solutions

Creating Custom Solutions

Our offerings leverage the richest and largest de-identified EMR and linked bio-specimen repository in the world, BioVU®. We utilize our diverse product offerings to create custom solutions curated to drive results for our clients.
Our offerings leverage the richest and largest de-identified EMR and linked bio-specimen repository in the world, BioVU®. We utilize our diverse product offerings to create custom solutions curated to drive results for our clients.

Real World Data Cohort Design

Nashville Biosciences recently worked with a clinical stage biotech to develop a synthetic control arm for its active single-arm clinical trial in a rare but…

 

Read more >

Disease Risk Modeling

Acute pancreatitis has become increasingly prevalent across the world, affecting nearly 85,000 individuals annually. Patients with acute pancreatitis experience…

 

Read more >

Molecular Data Generation

Nashville Biosciences recently worked with Pfizer’s Target Sciences and Technologies group to explore genetic targets for treating a serious metabolic disease with greatly increasing…

 

Read more >

Real World Data Cohort Design

Nashville Biosciences recently worked with a clinical stage biotech to develop a synthetic control arm for its active single-arm clinical trial in a rare but…

 

Read more >

Disease Risk Modeling

Acute pancreatitis has become increasingly prevalent across the world, affecting nearly 85,000 individuals annually. Patients with acute pancreatitis experience…

 

Read more >

Molecular Data Generation

Nashville Biosciences recently worked with Pfizer’s Target Sciences and Technologies group to explore genetic targets for treating a serious metabolic disease with greatly increasing…

 

Read more >

Exploring the Patient Journey

NashBio was created to make unique, complex data from the patient’s healthcare journey easy to use. We provide curated datasets within the context of each individual patient’s journey, so you understand the full picture of each patient’s data and are able to put the data to work for your unique goals.

Exploring the Patient Journey

NashBio was created to make unique, complex data from the patient’s healthcare journey easy to use. We provide curated datasets within the context of each individual patient’s journey, so you understand the full picture of each patient’s data and are able to put the data to work for your unique goals.

NashBio Data at a Glance

3

de-identified unique subjects

296

unique DNA samples with 120K genotyped

11

average length of clinical data

790

peer-reviewed publications

The Alliance for Genomic Discovery

AGD aims to accelerate the development of novel therapeutics through the use of large-scale genomics and the creation of a preeminent real-world genomic resource.

The Alliance for Genomic Discovery

AGD aims to accelerate the development of novel therapeutics through the use of large-scale genomics and the creation of a preeminent real-world genomic resource.

Don't Miss Out

Stay up to date on the latest NashBio news and events